Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
SK Telecom Co., Ltd. (SKM) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
SK Telecom Co., Ltd. (SKM) - free report >>
Image: Bigstock
Best Value Stocks to Buy for April 30th
Here are three stocks with buy rank and strong value characteristics for investors to consider today, April 30th:
SK Telecom Co. (SKM - Free Report) : This company which is the world's first commercial CDMA digital cellular service, carries a Zacks Rank #1 (Strong Buy), and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.5% over the last 60 days.
SK Telecom Co., Ltd. Price and Consensus
SK Telecom Co., Ltd. price-consensus-chart | SK Telecom Co., Ltd. Quote
SK Telecom has a price-to-earnings ratio (P/E) of 8.61 compared with 10.5 for the industry. The company possesses a Value Score of A.
SK Telecom Co., Ltd. PE Ratio (TTM)
SK Telecom Co., Ltd. pe-ratio-ttm | SK Telecom Co., Ltd. Quote
Takeda Pharmaceutical Co. (TAK - Free Report) : This research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs, carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.9% over the last 60 days.
Takeda Pharmaceutical Co. Price and Consensus
Takeda Pharmaceutical Co. price-consensus-chart | Takeda Pharmaceutical Co. Quote
Takeda Pharmaceutical has a price-to-earnings ratio (P/E) of 9.08 compared with 9.30 for the industry. The company possesses a Value Score of A.
Takeda Pharmaceutical Co. PE Ratio (TTM)
Takeda Pharmaceutical Co. pe-ratio-ttm | Takeda Pharmaceutical Co. Quote
PHINIA Inc. (PHIN - Free Report) : This company which is a premium solutions and components provider of manufacturing expertise, carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.2% over the last 60 days.
PHINIA Inc. Price and Consensus
PHINIA Inc. price-consensus-chart | PHINIA Inc. Quote
PHINIA has a price-to-earnings ratio (P/E) of 9.75 compared with 44.70 for the industry. The company possesses a Value Score of A.
PHINIA Inc. PE Ratio (TTM)
PHINIA Inc. pe-ratio-ttm | PHINIA Inc. Quote
See the full list of top ranked stocks here.
Learn more about the Value score and how it is calculated here.